"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
ArriVent and Alphamab Partner in $615.5 million collaboration for Novel ADC Cancer Treatments - GeneOnline
Mahmoud Hammad: The International Childhood Conference 5th Edition
Agenus announced updated Phase 1 data and progress botensilimab/balstilimab combination in metastatic MSS colorectal cancer
Paolo Tarantino on HER2 Testing and T-DXd Prediction
David B. Solit: >120,000 tumor/cfDNA samples analyzed
DESTINY-Breast06 is the first study to investigate a HER2-directed therapy in patients with HER2-ultralow tumors - ASCO
